Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102791694A reveals a streamlined synthesis for key fungicide intermediates. Discover cost-effective manufacturing routes for high-purity pyrazole derivatives.
Patent CN101781200B reveals a green amine transesterification method using ionic liquids, offering cost-effective and scalable production for pharmaceutical intermediates.
Novel oxidative esterification method using metalloporphyrins offers high selectivity and mild conditions for efficient carboxylic acid ester manufacturing.
Patent CN107417651A reveals high-yield FDCA production. Offers cost reduction and supply reliability for polymer and pharma intermediates.
Patent CN115724813B reveals a green Ru-catalyzed route for FDCA. Offers cost reduction in bio-based polymer manufacturing and high-purity supply chain reliability.
Improved process for 1,2-indane carboxylic acids via chiral auxiliaries. Enhances yield and scalability for pharmaceutical intermediate manufacturing.
Novel layered mixed oxide catalyst method for FDCA synthesis offering high yield and cost efficiency for polymer manufacturing supply chains and sustainable material production globally.
Novel patent CN117362227A enables high-yield quinolone ester synthesis. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113979940A reveals a cost-effective synthesis for naphthoquine ester using compound 5, offering improved yield and scalability for pharmaceutical manufacturers.
Patent CN101863854A details a cost-effective synthesis of 2-(3-cyano-4-isobutoxy)phenyl-4-methyl-5-thiazolecarboxylic acid using bromination, offering high purity and scalability.
Patent CN110669027B discloses efficient synthesis of tetrahydrofuran carboxylic acid intermediates for prostate cancer drugs, offering scalable routes and reduced purification costs.
Novel acridine activation route eliminates toxic reagents for APS-5 intermediates, ensuring high purity and scalable supply for diagnostic manufacturers.
Novel 7-step route avoids resolution, offering cost-effective manufacturing of chiral proline derivatives for pharmaceutical intermediates.
Novel resolution method for high-purity pharmaceutical intermediates. Cost-effective scale-up and supply chain reliability for kinase inhibitor synthesis.
Patent CN101899673B details a green electrochemical route for ethyl 3-oxocyclohexane-1-carboxylate, offering cost reduction and supply chain reliability for pharma intermediates.
Discover a patented green synthesis route for Tafamidis derivatives using sodium periodate. This method eliminates hazardous reagents, offering cost-effective and scalable pharmaceutical intermediate manufacturing.
Patent CN106458833A details a high-purity synthesis method for carboxylic acid halides, ensuring stability and cost reduction in electronic chemical manufacturing.
Novel photocatalytic method for gamma-hydroxycarboxylic acids using CO2. Offers mild conditions and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN102070533B details a novel synthesis route for Olmesartan intermediates offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Efficient catalytic hydrogenolysis route for high-purity agrochemical intermediates. Reduces steps and cost for chrysanthemic acid derivatives manufacturing.